Product Introduction
Tazact 4.5gm is a trusted antibiotic combination developed by Cipla, formulated to treat severe bacterial infections. The combination of Piperacillin and Tazobactam works synergistically to inhibit bacterial cell wall synthesis and prevent the breakdown of beta-lactam antibiotics. Tazact is effective against a broad spectrum of bacterial pathogens, providing fast relief from infections.
Indicated for both hospital and outpatient use, Tazact 4.5gm plays an important role in managing infections caused by susceptible organisms. Its dual-action formula makes it highly effective in combating infections of the lungs, urinary tract, skin, and abdominal region. Tazact ensures that patients experience quicker healing times and reduced risk of complications from infections.
Uses of Tazact 4.5gm (Piperacillin 4gm + Tazobactam 500mg)
Tazact is primarily indicated for:
- Respiratory Tract Infections– Used in treating pneumonia and other infections in the respiratory system.
- Skin and Soft Tissue Infections – Effective against infections in the skin and surrounding tissues.
- Urinary Tract Infections – Treats infections in the urinary tract.
- Intra-abdominal Infections – Helps control infections in the abdominal cavity.
By targeting a broad spectrum of bacterial pathogens, Tazact 4.5gm provides a reliable and potent solution for managing bacterial infections.
Side Effects of Tazact 4.5gm
Like any medication, Tazact may cause side effects. While most patients tolerate it well, some may experience:
- Nausea or vomiting
- Diarrhea
- Rash
- Headache
- Abdominal pain
- Elevated liver enzymes
Less Common Side Effects
Less common side effects of Tazact may include:
- Allergic reactions
- Confusion
- Blood disorders
- Kidney problems
- Seizures (rare)
We are pleased to offer you a powerful solution.
Tazact 4.5gm is a trusted treatment option for bacterial infections. It is developed with cutting-edge technology to ensure maximum effectiveness while minimizing side effects. With its broad-spectrum action, Tazact is a vital tool in modern infection control.
- The standard dosage is determined by the type of infection and severity.
- Administer as prescribed by your healthcare provider, typically through intravenous injection.
- Treatment duration may vary based on infection type and response to therapy.
- Do not self-adjust dosage without medical advice.
Tazact 4.5gm combines the action of two antibiotics: Piperacillin and Tazobactam. Piperacillin is a broad-spectrum antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam acts as a beta-lactamase inhibitor, preventing the breakdown of Piperacillin by resistant bacteria. Together, these components offer a powerful treatment for a wide range of bacterial infections.
- Effective against a broad spectrum of bacterial pathogens.
- Combats both gram-positive and gram-negative bacteria.
- Reduces infection severity and speeds up recovery.
- Dual-action formula enhances its effectiveness against resistant bacteria.
- Tazact should be used with caution in patients with a history of kidney or liver disease.
- Not recommended for patients with known allergies to penicillins or beta-lactam antibiotics.
- Pregnancy and lactation: Consult your healthcare provider before use.
- Regular monitoring of liver and kidney function is advised during prolonged use.
- Gastrointestinal issues
- Allergic reactions
- Liver enzyme abnormalities
- Rash
- Kidney dysfunction (in rare cases)
Tazact 4.5gm, from Cipla, offers the following benefits:
- Proven Efficacy in treating a wide range of bacterial infections.
- Dual-action formula for enhanced effectiveness against resistant bacteria.
- Reliability Backed by years of clinical success and research.